JP Stock MarketDetailed Quotes

4523 Eisai

Watchlist
  • 4093.0
  • +17.0+0.42%
20min DelayTrading Apr 30 09:04 JST
1.19TMarket Cap27.68P/E (Static)

About Eisai Company

Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.

Company Profile

Symbol4523
Company NameEisai
Founded1941-12-06
MarketTSE Prime
Employees11170
Fiscal Year Ends03-31
Address4-6-10 Koishikawa Bunkyo-ku
Zip Code112-8088
Phone03-3817-3700

Company Executives

  • Name
  • Position
  • Salary
  • Haruo Naito
  • Director, Corporate Officer and Chief Executive Officer
  • --
  • Kenta Takahashi
  • General Counsel, Executive Vice President, Chief Compliance Officer and Director
  • --
  • Fumihiko Ike
  • Chairman of the Board
  • --
  • Yoshiteru Kato
  • Director
  • --
  • Hiroyuki Kato
  • Director
  • --
  • Yumiko Miwa
  • Independent Director
  • --
  • Yuko Yasuda
  • Independent Director
  • --
  • Toru Moriyama
  • Independent Director
  • --
  • Takuji Kanai
  • Independent Director
  • --
  • Ryota Miura
  • Independent Director
  • --
  • Richard Thornley
  • Independent Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More